Echoing the scientific literature, they write of ipamorelin that we lack sufficient information to know whether the drug would cause harm if administered to humans via [injection]. The peptide pralmorelin (or GHRP-2) is clinically approved in Japan, but only as a way to diagnose adults who are deficient in growth hormone
Yes, but only when a significant, separately identifiable E/M service is performed beyond the routine pre- and post-injection assessment
In the UK, hydroxocobalamin is the standard form used for intramuscular injections, and routine monitoring of serum B12 levels during replacement therapy is generally not required once treatment is established
Ipamorelin is a ghrelin mimetic, meaning it stimulates GH release through a completely separate receptor pathway
Heres what to watch out for
You will need vitamin B12 injections